Retour
Prix Inhibikase Therapeutics Inc (IKT)
Graphique du cours de l'action IKT
IKT Gagner
Inhibikase Therapeutics Inc
$1.65
0.3%
$0
À partir d'aujourd'hui :Feb 10, 13:13:29 GMT-5
Statistiques clés
Clôture préc.
$1.65
Prix d'ouverture
$1.65
Plage de la journée
$1.6 - $1.65
Plage de 52 semaines
$1.33 - $3.32
Volume
188.9K
Volume moyen
579.3K
BPA (TTM)
-1.15
Rendement en dividend
--
Capitalisation boursière
$200.0M
Qu’est-ce que IKT ?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved